Court Opinion

ID: 9910429
Source: CourtListenerOpinion
Date Created: 2023-12-15 17:08:46.944017+00
Date Added: 2024-06-11T12:52:58.736715
License: Public Domain

J-A17019-23

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT O.P. 65.37

    HANNAH LAHR, INDIVIDUALLY AND   :              IN THE SUPERIOR COURT OF
    AS EXECUTRIX OF THE ESTATE OF   :                   PENNSYLVANIA
    ANNALISE MEDINA-DIAZ, DECEASED  :
                                    :
                                    :
               v.                   :
                                    :
                                    :
    LEHIGH VALLEY HOSPITAL, INC.,   :              No. 2802 EDA 2022
    LEHIGH VALLEY PHYSICIANS GROUP, :
    LAURA A. YOUNG, M.D. AND MOLLY  :
    S. PETERS, M.D.                 :
                                    :
                    Appellants      :

                 Appeal from the Order Entered October 3, 2022
                 In the Court of Common Pleas of Lehigh County
                      Civil Division at No(s): 2021-C-0010

BEFORE:      KING, J., SULLIVAN, J., and PELLEGRINI, J.*

MEMORANDUM BY SULLIVAN, J.:                             FILED DECEMBER 15, 2023

       Lehigh Valley Hospital, Inc. (“LVH”),1 Lehigh Valley Physicians Group

(“Group”), Laura A. Young, M.D. (“Dr. Young”), and Molly S. Peters, M.D. (“Dr.

Peters”)    (collectively,   “Appellants”)     appeal   from   the   discovery   order

compelling disclosure of three patient safety reports2 related to Hannah Lahr

____________________________________________

* Retired Senior Judge assigned to the Superior Court.

1  LVH is responsible for a network of hospitals, including hospitals in
Muhlenberg (“LVH-Muhlenberg”) and Cedar Crest (“LVH-Cedar Crest”). Some
of the documents in the record refer to the Lehigh Valley Hospital Network.

2 The discovery order is immediately appealable pursuant to the collateral
order doctrine. See Pa.R.A.P. 313; Ford-Bey v. Professional Anesthesia
Services, 302 A.3d 789, 794-95 (Pa. Super. 2023); Ungurian v. Beyzman,
232 A.3d 786, 793 n.10 (Pa. Super. 2020).
J-A17019-23

(“Lahr”) and the death of Lahr’s newborn baby, Annalise Medina-Diaz

(“Medina-Diaz”).      We affirm and direct Lahr’s counsel to file a certification

consistent with this decision.3

       We summarize the background to this appeal from the allegations in

Lahr’s first amended complaint. See First Amended Complaint, 4/5/21, at 2-

8.   Group provided Lahr with prenatal care when she was pregnant with

Medina-Diaz. In August 2019, around the time of Lahr’s expected due date,

she experienced symptoms, including cramping, bloody vaginal discharge, and

____________________________________________

3 We note that the trial court reviewed the three patient safety reports in
camera and directed them to be sealed. After Appellants took this appeal and
requested a stay of the trial court’s order compelling production of the patient
safety report, this Court twice ordered that the reports “shall not be made
part of the record in the trial court at this time.” Order, 11/23/22 at 1
(emphasis added); Order 12/13/22, at 1 (emphasis added). The trial court
subsequently and inexplicably electronically transmitted to this Court the
certified record which included copies of the contested reports as an unsealed
exhibit. The exhibit, therefore, was accessible to all counsel via this Court’s
PACMS system under the file name “Exhibit-10.” While this Court took steps
to limit all counsels’ access to the exhibit upon discovery of this issue, it
appears that counsel for the parties, including Lahr’s counsel, already
accessed the carelessly unsealed exhibit from this Court’s electronic records
system in December 2022.

While we decline at this juncture to find this appeal moot based on the trial
court’s violation of this Court’s prior directives, see In re 2014 Allegheny
County Investigating Grand Jury, 173 A.3d 653, 656 (Pa. 2017) (internal
citation omitted), we direct Lahr’s counsel to immediately destroy any copies
of “Exhibit-10” or the patient safety reports he obtained. We further order
counsel to file in this Court, within five days of this decision, a certification
indicating whether he reviewed the contents of “Exhibit-10” or the patient
safety reports and whether he has disseminated the patient safety reports or
any of the information contained therein. Additionally, Lahr’s counsel shall
verify in the certification that he has destroyed any and all copies of “Exhibit-
10” that he obtained or produced.

                                           -2-
J-A17019-23

fever, which she reported to on-call providers at Group. The on-call providers

advised Lahr to take Tylenol and visit Group’s office. On August 13, 2019,

Lahr instead went to LVH-Muhlenberg, where she was admitted for the

induction of labor. Dr. Young and Dr. Peters, who were affiliated with Group

and LVH, were Lahr’s attending obstetricians-gynecologists (“OB-GYNs”).

Lahr gave birth to Medina-Diaz in the early morning hours of August 14, 2019.

Medina-Diaz was in critical condition and transferred to LVH-Cedar Crest.

Later that evening, Medina-Diaz died of complications related to infections.

There is no dispute that between August 14 and 15, 2019, LVH’s healthcare

workers used LVH’s electronic reporting system to create the three patient

safety reports concerning Lahr and/or Medina-Diaz that are the subject of this

appeal.

      Lahr, individually and as executrix of Medina-Diaz’s estate, commenced

the underlying civil action asserting medical malpractice and related claims

against Appellants. The trial court summarized the procedural history and its

findings of fact relevant to the discovery dispute over the patient safety

reports as follows:

            On December 16, 2021, [Lahr] moved to compel
      [Appellants] to produce “patient safety reports” regarding . . .
      Lahr and/or . . . Medina-Diaz. [Appellants] asserted that the
      patient safety reports are immune from discovery under the
      Medical Care Availability and Reduction of Error (“MCARE”) Act,

                                    -3-
J-A17019-23

       40 P.S. §§ 1303.101-1303.910, and/or the Peer Review Protection
       Act (“PRPA”), 63 P.S. §§ 425.1-425.4.[4]

               The [c]ourt heard oral argument regarding [Lahr’s] motion
       . . . [and] entered an [o]rder . . . directing [Appellants] to provide
       the [c]ourt with the patient safety reports for an in-camera
       review, and scheduling an evidentiary hearing. The [c]ourt
       reviewed the reports in camera and held an evidentiary hearing .
       . ..

             At the hearing held on March 31, 2022, [the court] heard
       testimony from Gwenis L. Browning [“(Browning”)], Administrator
       of Patient Safety/Patient Safety Officer and Director of Patient
       Safety/Patient Safety Officer; Kay Ann Young, Director of the
       Department of OB-GYN Quality Assurance and Performance
       Improvement; and Carolyn Coleman, Administrator for Risk
       Management. . . .

               In accordance with [MCARE], [LVH] adopted a patient safety
       plan. The patient safety plan encourages healthcare workers to
       report events that they witness or participate in at LVH[] medical
       facilities. In order to implement the patient safety plan, LVH[]
       adopted a patient safety reporting policy, which provides “a
       standardized mechanism for identifying, reporting, investigating,
       trending and resolving incidents.”

              A healthcare worker may report a “patient safety event” by
       submitting a “patient safety report” to the patient safety office. A
       healthcare worker may electronically file a patient safety report,
       call the hotline, complete a hard copy form, call the patient safety
       office, or use the internal texting system. The healthcare worker
       making the report may remain anonymous if he or she chooses to
       do so.

             The patient safety officer oversees the patient safety plan
       and patient safety reporting policy. After reviewing a patient
       safety report, the patient safety officer determines whether to
       conduct an investigation, which may include reviewing relevant
____________________________________________

4 At various points during the litigation of this discovery dispute, Appellants

and Lahr argued the applicability of privileges under MCARE section 311(a),
entitled “Prepared materials,” and 311(d), entitled “Received materials,” 40
P.S. § 1303.311(a), (d), as well as PRPA section 425.4, entitled
“Confidentiality of review organization’s records.” See 63 P.S. § 425.4.

                                           -4-
J-A17019-23

       medical records, conducting a root cause analysis, and reaching
       out to the patient and other individuals involved in the event. At
       the conclusion of an investigation, the patient safety officer
       determines whether the event must be reported to the
       Pennsylvania Patient Safety Authority [(also referred to herein as
       “the PPSA” or “the authority”)].

                                         ****

              There are three patient safety reports involving [Lahr and/or
       Medina-Diaz]. The patient safety office investigated the events
       described in the patient safety reports and, during the course of
       this investigation, the patient safety officer led a group, consisting
       of frontline staff and leadership personnel, that conducted a root
       cause analysis.[5] At the conclusion of its investigation, the patient
       safety office classified two of the three reports as “incidents” and
       one event report as a “non-event,” and in accordance with the
       provided taxonomy, reported the two events classified as
       “incidents” to the Pennsylvania Patient Safety Authority.

             Ms. Young received the three patient safety reports in
       electronic form and, upon evaluation, determined that the events
       described in these reports should be subject to peer review.
       Although Ms. Young typically uploads summaries of patient safety
       reports into the electronic peer review file, she does not know
       whether she uploaded summaries of the patient safety reports
       regarding [Lahr and/or Medina-Diaz] into the electronic peer
       review file. On September 6, 2019, the Obstetrics Peer Review
       Committee engaged in peer review by reviewing the electronic
       peer review data.

Trial Court Opinion, 12/28/22, at 1-4 (some dates, capitalization and footnote

omitted; italics added).

____________________________________________

5 It is unclear whether Browning participated in the investigation, and it
appears another patient safety officer, who did not testify at the hearing,
conducted the root cause analysis. See N.T., 3/31/22, at 44. Browning
testified that the patient safety reports and addendums based on the root
cause analysis are kept in one file or “repository” maintained by the patient
safety office. Id. at 33.

                                           -5-
J-A17019-23

       In June 2022, the trial court granted Lahr’s motion to compel production

of the patient safety reports. The court found, inter alia, the MCARE and PRPA

confidentiality provisions did not apply because the reports contained

information otherwise available from an original source, such as a medical

record.6 See Order; 6/21/22, at 1; Memorandum Opinion, 6/21/22, at 11-

12, 16.7 Appellants filed a motion for reconsideration (“first reconsideration

motion”) of the trial court’s decision under MCARE. At oral arguments on the

first reconsideration motion, Appellants conceded that they produced no

evidence that a patient safety committee reviewed the patient safety reports.

See N.T., 9/19/22, at 7. Appellants, however, asserted section 311(a) should

apply and the trial court erred in its application of the original source provision.

See id. at 11-14. The court thereafter concluded that it had properly denied

Appellants’ claim of an MCARE privilege but had done so for the wrong reason.

See Memorandum Opinion, 10/3/22, at 8.             The court, citing Venosh v.

Henzes, 31 Pa. D. & C. 5th 411, 2013 WL 9593953 (Lackawanna Cty. 2013),

____________________________________________

6 Specifically, the trial court entered three orders in June 2022: a June 17,

2022 order and memorandum opinion compelling disclosure of the patient
safety reports; a June 21, 2022 order vacating the June 17, 2022 order; and
a June 21, 2022 order and memorandum opinion compelling disclosure of the
patient safety reports with amended language directing the sealing of the
patient safety reports. We refer to the June 21, 2022 order compelling
disclosure as the “June 2022 order.”

7 The trial court also concluded that PRPA’s evidentiary protections did not
apply because Appellants failed to establish a peer review committee reviewed
the information in the patient safety reports. See Memorandum Opinion,
6/21/22, at 11.

                                           -6-
J-A17019-23

aff'd, 105 A.3d 788 (Pa. Super. 2014) (unpublished memorandum), reasoned

that section 311(a) did not apply because a patient safety committee did not

review the patient safety reports. See id. at 5-8.8

       On October 3, 2022, the court vacated its June 2022 order9 and issued

a new order and a memorandum opinion requiring disclosure of the patient

safety reports. See Order, 10/3/22, at 1; Memorandum Opinion, 10/3/22, at

1-8. Appellants filed a motion for reconsideration (“second reconsideration

motion”) and timely appealed the October 3, 2022 order. Appellants and the

court have complied with Pa.R.A.P. 1925.10
____________________________________________

8 In Venosh, the court of common pleas discerned three elements to a claim

of privilege under section 311(a): (1) the document was “solely prepared or
created for the purpose of compliance with” MCARE; (2) the document
“arise[s] out of matters reviewed by the patient safety committee . . . or the
governing board” pursuant to section 310(b); and (3) the document is not
otherwise available “from original sources.” Venosh, 2013 WL 9593953, at
*10. The court further reasoned that section 311(a) did not apply “if the
investigation of an incident by the defendant hospital was not commenced at
the request of or by the defendant’s Patient Safety Committee” or if a patient
safety committee, or the hospital’s governing board, did not review a
document. Id. (internal citations and quotations omitted). It is well settled
that the decision of a court of common pleas does not bind this Court, but we
may consider the reasoning as persuasive. See Darrow v. PPL Elec.
Utilities Corp., 266 A.3d 1105, 1112 n.6 (Pa. Super. 2021).

9 Because the June 2022 order was not a final order, the court retained
jurisdiction to vacate it more than thirty days after its entry. See 42 Pa.C.S.A.
§ 5505; see also Mente Chevrolet, Oldsmobile, Inc. v. Swoyer, 710 A.2d
632, 633 (Pa. Super. 1998) (noting that “the thirty-day time limit for
reconsideration imposed by 42 Pa.C.S.A. § 5505 applies only to final orders”).

10 In its Rule 1925(a) opinion, the trial court suggested Appellants withdrew

their claim under PRPA and waived their claims under MCARE section 311(d).
Trial Court Opinion, 12/28/22, at 5 n.2, 11 n.5. However, the court elected
to discuss section 311(d) in its Rule 1925(a) opinion. See id. at 11.

                                           -7-
J-A17019-23

      Appellants raise the following issues for our review:

      1. Whether the trial court committed an error of law and/or
         abused its discretion in requiring a hospital to produce patient
         safety reports: (i) prepared in accordance with the
         requirements of [MCARE], with the specific intention that they
         would remain confidential and protected from disclosure in a
         civil proceeding, (ii) in circumstances where the information
         contained therein is the same information the hospital
         conveyed to the Pennsylvania Patient Safety Authority which
         MCARE section 311(d) separately protects?

      2. Whether the trial court erred and/or abused its discretion by
         failing to find that section 311(d) of the MCARE Act—which
         protects information provided to, as well as information
         disseminated from, the Pennsylvania Patient Safety Authority
         . . . —protected a hospital’s patient safety reports from
         discovery where the undisputed evidence established that the
         reports in question were sent to the [a]uthority pursuant to
         section 311(d) of the Act?

      3. Whether the trial court erred and/or abused its discretion by
         failing to find that a hospital’s patient safety reports were
         protected from discovery under [PRPA], in circumstances
         where the undisputed evidence established that the documents
         were “sent to and reviewed by” a peer review committee, and,
         thus, fell within the purview of the statute, and where
         [Appellants]—who properly raised and preserved the peer
         review privilege in their response to [Lahr’s] motion to
         compel—did not waive the issue?

Appellants’ Brief at 7-8 (some capitalization and emphasis omitted).

      This appeal implicates the trial court’s discovery order rejecting

Appellants’ claims of statutory privileges. Our standard of review is as follows:

      In reviewing the propriety of a discovery order, our standard of
      review is whether the trial court committed an abuse of discretion.
      Abuse of discretion occurs if the trial court renders a judgment
      that is manifestly unreasonable, arbitrary or capricious; that fails
      to apply the law; or that is motivated by partiality, prejudice, bias
      or ill-will.

                                      -8-
J-A17019-23

Carlino E. Brandywine, L.P. v. Brandywine Village Associates, 260 A.3d

179, 195-96 (Pa. Super. 2021) (internal citations, quotations, and brackets

omitted) (“Carlino”). When a claim of privilege requires consideration of a

question of law, such as the interpretation of a statute, our standard of review

is de novo, and the scope of our review is plenary. See Ungurian, 232 A.3d

at 794.

      Pennsylvania law imposes a shifting burden of proof in disputes

involving the disclosure of allegedly privileged materials. The party asserting

a privilege must initially produce facts to properly invoke the privilege; once

the privilege is properly invoked, the party seeking disclosure bears the

burden of showing that disclosure should be compelled either because the

privilege has been waived or because an exception to the privilege applies.

See Carlino, 260 A.3d at 197. If the party asserting the privilege produces

insufficient facts to invoke the privilege, then the burden never shifts to the

party seeking disclosure. See id.

      In their first issue, Appellants assert error in the trial court’s

interpretation and application of MCARE section 311(a). Before addressing

this issue, it is helpful to provide the background to the evidentiary protections

in MCARE section 311.

      MCARE Chapter 3, entitled “Patient Safety” (“Chapter 3”), “relates to

the reduction of medical errors for the purpose of ensuring patient safety.” 40

P.S. § 1303.301. Chapter 3 establishes the PPSA as an independent agency

which, along with the Pennsylvania Department of               Health   (or “the

                                      -9-
J-A17019-23

department”), receives reports, collects data, and makes recommendations to

a hospital. See id. §§ 1303.303, 1303.304(a)(5)-(7), 1303.306(a)(2)-(3).

       Chapter 3 requires medical facilities to develop, implement, and comply

with, a patient safety plan, see id. § 1303.307, and establish internal

reporting systems for healthcare workers to report “incidents” and “serious

events.” See id. §§ 1303.307(b)(3), 1303.308(a).11 Healthcare workers who

reasonably believe an incident or serious event occurred must make a report,

pursuant to the procedures in the patient safety plan, no later than twenty-

four hours after the occurrence or the discovery of the occurrence. See id.

§ 1303.308(a).

       A hospital’s patient safety plan must also designate a patient safety

officer and establish a patient safety committee. See id. § 1303.307(b)(1)-

(2). A patient safety officer must: serve on the patient safety committee;

ensure the investigation of all reports of incidents and serious events; take

action as is immediately necessary to ensure patient safety as a result of any

investigation; and report to the patient safety committee any action taken to

promote patient safety as a result of the investigation.               See id.

§ 1303.309(1)-(4).
____________________________________________

11 Chapter 3 defines an “incident” as “[a]n event, occurrence or situation
involving the clinical care of a patient in a medical facility which could have
injured the patient but did not either cause an unanticipated injury or require
the delivery of additional health care services to the patient[,]” and a “serious
event” as “[a]n event, occurrence or situation involving the clinical care of a
patient in a medical facility that results in death or compromises patient safety
and results in an unanticipated injury requiring the delivery of additional
health care services to the patient.” 40 P.S. § 1303.302.

                                          - 10 -
J-A17019-23

      Section 310(b) requires a patient safety committee to:

      (1) receive reports from the patient safety officer.

      (2) evaluate the patient safety officer’s investigations and actions
      on all reports.

      (3) review and evaluate the quality of patient safety measures
      utilized by the medical facility, which must include consideration
      of reports made under sections 304(a)(5) and (b), 307(b)(3) and
      308(a).

      (4) make recommendations to eliminate future serious events and
      incidents.

      (5) give quarterly reports to the administrative officer and
      governing body of the medical facility about the number of serious
      events and incidents and the committee’s recommendations to
      eliminate future serious events and incidents.

Id. § 1303.310(b). Additionally, a hospital must report incidents to the PPSA.

See id. § 1303.313(b).

      When establishing these reporting requirements, the General Assembly

created a corresponding “confidentiality and compliance” section in MCARE,

which, in relevant part, protects documents prepared for the purpose of

compliance with MCARE, prohibits testimony on certain matters by members

and participants of meetings of the patient safety committee or the governing

board of a medical facility, and protects materials received by the PPSA. See

id. § 1303.311(a), (b), (d).

      Appellants’ first issue requires consideration of the following provisions

of section 311:

      (a) Prepared materials.--Any documents, materials or
      information solely prepared or created for the purpose of
      compliance with section 310(b) or of reporting under section

                                     - 11 -
J-A17019-23

       304(a)(5) or (b), 306(a)(2) or (3), 307(b)(3), 308(a), 309(4),
       310(b)(5) or 313 which arise out of matters reviewed by the
       patient safety committee pursuant to section 310(b) or the
       governing board of a medical facility pursuant to section 310(b)
       are confidential and shall not be discoverable or admissible as
       evidence in any civil or administrative action or proceeding. Any
       documents, materials, records or information that would
       otherwise be available from original sources shall not be construed
       as immune from discovery or use in any civil or administrative
       action or proceeding merely because they were presented to the
       patient safety committee or governing board of a medical facility.

                                         ****

       (c) Applicability.--The confidentiality protections set forth in
       subsections (a) and (b)[12] shall only apply to the documents,
       materials or information prepared or created pursuant to the
       responsibilities of the patient safety committee or governing board
       of a medical facility set forth in section 310(b).

40 P.S. § 1303.311(a), (c) (footnote omitted).

       Appellants argue LVH implemented a patient safety plan pursuant to

section 307 and a reporting system required by section 307(b)(3). They claim

LVH’s healthcare workers solely prepared or created the contested patient
____________________________________________

12 Subsection (b) states:

       No person who performs responsibilities for or participates in
       meetings of the patient safety committee or governing board of a
       medical facility pursuant to section 310(b) shall be allowed to
       testify as to any matters within the knowledge gained by the
       person’s responsibilities or participation on the patient safety
       committee or governing board of a medical facility, provided,
       however, the person shall be allowed to testify as to any matters
       within the person's knowledge which was gained outside of the
       person’s responsibilities or participation on the patient safety
       committee or governing board of a medical facility pursuant to
       section 310(b).

40 P.S. § 1303.311(b).

                                          - 12 -
J-A17019-23

safety reports for the purpose of compliance with section 308(a), and LVH

reported the two events deemed incidents to the PPSA as required by section

313. Appellants assert the evidentiary protections in section 311(a) should

apply to all three patient reports based on LVH’s and its healthcare workers’

compliance with the reporting requirements of Chapter 3.

      Appellants further contend the trial court erred in its interpretation and

application of section 311(a) by requiring an actual review of the patient safety

reports by a patient safety committee. Section 311(a), they argue, does not

state that a document must be “actually reviewed” but requires only that a

document “arise out of matters reviewed” by a patient safety committee.

Appellants posit the “arise out of matters reviewed” requirement extends

section 311(a)’s protection to types of documents typically reviewed by a

patient safety committee.       Appellants insist the trial court impermissibly

altered the plain meaning of section 311(a) and erred in relying on Venosh

to find an “actual review” requirement. Further, Appellants argue the creation

of an “actual review” requirement in section 311(a), would undermine the

purposes of MCARE to encourage healthcare workers and hospitals to report

incidents and serious events.

      The trial court initially agreed with Appellants that the contested patient

safety reports were solely created or prepared for the purposes of complying

with MCARE. See Trial Court Opinion, 12/28/22, at 8. However, the court

determined Appellants failed to present any evidence that a patient safety

committee reviewed the reports. See id. at 9. The court, citing Venosh,

                                      - 13 -
J-A17019-23

thus concluded Appellants failed to establish a privilege under section 311(a).

The court rejected Appellants’ claim that section 311(a) did not require a

patient safety committee to actually review a document as inconsistent with

the plain language of section 311(a). See id. at 5-9.13

       Following our review, we conclude that neither the trial court nor

Appellants offer an interpretation of section 311(a)’s “review” requirement

consistent with statute. In so concluding, we are mindful that the object of

statutory interpretation is to ascertain and effectuate the intention of the

General Assembly, giving effect, if possible, to all provisions of the statutory

provisions under review.         See 1 Pa.C.S.A. § 1921(a).   A statute’s plain

language is the best indication of legislative intent.        See 1 Pa.C.S.A.

§ 1921(b). Furthermore, we note that evidentiary privileges are disfavored

because they operate in derogation of the search for truth. See Reginelli v.

Boggs, 181 A.3d 293, 300 (Pa. 2018). However, a statutory privilege reflects

the General Assembly’s public policy determinations concerning the need for

an evidentiary protection. See id. Thus, a court may not abrogate a statutory

protection unless a clear basis for doing so exists in a statute, the common

law, or constitutional principles. See id.
____________________________________________

13 Lahr agrees with the trial court’s interpretation of section 311(a) as
requiring an actual review of the patient safety report. However, Lahr asserts
that Appellants failed to establish the healthcare workers solely prepared or
created the patient safety reports for the purpose of compliance with MCARE.
She also contends that MCARE section 311(a)’s original source provision
defeated Appellants’ claim that the patient safety reports were confidential
and could not be discovered.

                                          - 14 -
J-A17019-23

       The relevant phrase at issue in this appeal is section 311(a)’s protections

of “documents, materials or information solely prepared or created for the

purpose of . . . reporting under [section 308(a)] which arise out of matters

reviewed by the patient safety committee pursuant to section 310(b) or the

governing board of a medical facility pursuant to section 310(b) . . . .” 40

P.S. § 1303.311(a).

       We initially discern no basis to disturb the trial court’s conclusion that

the three contested patient safety reports were documents solely prepared or

created for the purpose of compliance with reporting under section 308(a).

See Trial Court Opinion, 12/28/22, at 8.            LVH presented evidence that it

implemented a patient safety plan as required by section 307, and the patient

safety plan established a system for internal reports as required by sections

307(b) and 308(a). See N.T., 3/31/22, at 12, 15; LVH Exhibits 2 (patient

safety plan) and 3 (reporting policy).14           A review of the contested patient

safety reports supports the court’s finding that the reporting healthcare

workers utilized the system to prepare or create the patient safety reports

pursuant to section 308(a)’s requirements to report occurrences they

reasonably believed were incidents or serious events. See Trial Court Opinion,

12/28/22, at 8. Moreover, we note that LVH reported two incidents to the

PPSA upon the determination that two of the three patient safety reports

constituted incidents under MCARE. See 40 P.S. § 1303.313(b). Thus, we
____________________________________________

14 LVH referred to its patient safety committee as a “patient safety council.”

See LVH Exhibit 2.

                                          - 15 -
J-A17019-23

agree with the trial court that Appellants established the three patient safety

reports were solely prepared or created for the purpose of reporting under

MCARE.

       We now turn to the crux of this appeal—the phrase “which arise out of

matters reviewed by the patient safety committee . . ..”              40 P.S.

§ 1303.311(a). This phrase limits the scope of section 311(a)’s protections,

but the term “matters” is not defined by MCARE. However, the term’s plain

meaning, and its use in other provisions of section 311, support reading

“matters” more broadly than “documents, materials or information.”

       Dictionary definitions of “matter” or “matters” include “[a] subject of

concern, feeling, or actions[,]” The American Heritage Dictionary of the

English Language, 5th Ed. at 1084 (defining “matters”), and “[t]he situation

in question,” Collins English Dictionary (defining “matters”).15         Other

provisions of section 311 prohibit certain witnesses from testifying “as to any

matters within the knowledge gained by the person’s responsibilities or

participation on the patient safety committee or governing board of a medical

facility[,]” but permit testimony “concerning matters within the person’s

knowledge which was gained outside” of the witness’s responsibility or

participation in such meetings. 40 P.S. § 1303.311(b) (emphases added).

Section 311(e), which applies to current and former employees of the PPSA,

the Department of Health, and the Department of State, prohibits testimony

____________________________________________

15 See https://www.collinsdictionary.com/us/dictionary/english/matters.

                                          - 16 -
J-A17019-23

“as to any matters gained by reason of his or her review of documents,

materials, records or information” submitted to the PPSA pursuant to MCARE.

Id. § 1303.311(e) (emphasis added).

       Thus, it appears the General Assembly did not intend “matters” to be

interchangeable with “documents, materials, or information.” Consistent with

the ordinary meanings of “matters” as a broad subject of concern or a situation

in question, we conclude the phrase “matters reviewed” in section 311(a) does

not require the party claiming a section 311(a) protection to establish a patient

safety committee or governing board actually reviewed a contested document.

Therefore, we find support for Appellants’ argument that the trial court erred

in interpreting section 311(a) as requiring an actual review of the patient

safety reports by a patient safety committee or a governing board.16

       However, Appellants’ interpretation of the phrase “matters reviewed” to

mean documents “typically” considered by a patient safety committee or

____________________________________________

16 Further textual evidence supports holding that section 311(a) does not
require an “actual review” of a specific document. Had the General Assembly
intended the protections in section 311(a) to attach only when a document
was presented to or actually reviewed by a patient safety committee or
governing board, it could have stated so expressly, as it did in the original
source provision. See 40 P.S. § 1303.311(a) (stating “documents . . . that
would otherwise be available from original sources shall not be construed as
immune from discovery . . . merely because they were presented to the
patient safety committee or governing board of a medical facility”)
(emphasis added). Furthermore, requiring a party to prove the “actual
review” of a specific document would be inconsistent with section 311(b)’s
prohibition of testimony “as to any matters within the knowledge gained by
the person’s responsibilities or participation on the patient safety committee
or governing board of a medical facility.” 40 P.S. § 1303.311(b).

                                          - 17 -
J-A17019-23

governing board requires further consideration. Section 311(a) specifically

requires that a protected document arise out of matters reviewed pursuant to

their section 310(b) responsibilities.    Matters pursuant to section 310(b)

include the governing board’s duty to receive quarterly reports from the

patient safety committee and the patient safety committee’s duties to, inter

alia, receive reports from the patient safety officer, “[e]valuate investigations

and actions of the patient safety officer on all reports[,]” and “[r]eview and

evaluate the quality of patient safety measures utilized by the medical facility,”

which must also include consideration of reports under 308(a).           40 P.S.

§§ 1303.310(b)(2), (3), (5). Significantly, section 311(c) also states “[t]he

confidentiality protections set forth in subsections (a) . . . shall only apply to

the documents, materials or information prepared or created pursuant to the

responsibilities of the patient safety committee or governing board of a

medical facility set forth in section 310(b).”    Id. § 1303.311(c).     Reading

section 311(a) and (c)’s requirements together, it is clear the General

Assembly intended      that a party seeking section 311(a)’s           protection

demonstrate a document was prepared or created pursuant to a patient safety

committee’s or governing board’s responsibility, see id., and the document

arose from matters reviewed by the patient safety committee, such as

receiving the patient safety officer’s report, evaluating the patient safety

officer’s investigation and actions on all reports, or reviewing and evaluating

the quality of a hospital’s patient safety measures. See id. §§ 1303.310(b),

1303.311(a).

                                      - 18 -
J-A17019-23

      Based on the foregoing, we discern no merit to Appellants’ assertion

that section 311(a) applies simply because the patient safety reports are the

types of documents that typically are reviewed by a patient safety committee

or governing board pursuant to section 310(b). The fact that documents are

typically reviewed satisfies section 311(c)’s requirement that a document be

prepared or created pursuant to a responsibility of a patient safety committee

or governing board, such as the patient safety committee’s responsibility to

consider section 308(a) reports when reviewing and evaluating a hospital’s

patient safety measure. See id. §§ 1303.310(b)(3), 1303.311(c). However,

the General Assembly required more in section 311(a): the protected

document must arise out of matters reviewed by the patient safety

committee or governing board pursuant to section 310(b). To conclude that

section 311(a) applies based on the type of document and the intent or

purpose to comply with MCARE, would nullify the phrase “matters reviewed”

in favor of “matters typically reviewed.” Such an interpretation would not only

add language to section 311(a) but also conflate section 311(a)’s language

concerning a document which arises out of matters reviewed with section

311(c)’s language concerning a document prepared or created pursuant to

the patient safety committee’s or governing board’s general responsibilities

under section 310(b). This Court cannot read section 311(a) in a manner as

to render section 311(c) superfluous, and we conclude that the phrase

“matters reviewed” required Appellants to demonstrate more than the fact a

                                    - 19 -
J-A17019-23

patient safety committee or governing board would typically review the patient

safety reports.

      With these principles in mind, we turn to the record in this appeal.

Appellants conceded that they produced no evidence that the patient safety

committee reviewed the patient safety reports.         See N.T., 9/19/22, at 7.

While we have concluded that Appellants were not required to prove an actual

review of the patient safety reports by the patient safety committee, the

record further reveals Appellants provided no evidence that the patient safety

reports arose out of any matters reviewed by the patient safety committee or

the governing board pursuant to section 310(b). There was no evidence that

patient safety committee received a patient safety officer’s report, evaluated

the patient safety officer’s investigation and actions, or reviewed or evaluated

the quality of LVH’s patient safety measures upon a consideration the patient

safety reports.     See 40 P.S. § 1303.310(b)(1)-(3).             Browning, the

Administrator of Patient Safety/Patient Safety Officer and Director of Patient

Safety/Patient Safety Officer, testified the patient safety officer took no further

actions after the matter was referred to peer review and two incident reports

were filed with the PPSA. See N.T., 3/31/22, at 35. Appellants provided no

evidence that the patient safety committee even received or accessed the

patient safety reports, a patient safety file, or a report from the patient safety

                                      - 20 -
J-A17019-23

officer.17 Similarly, there was no evidence that the patient safety committee

prepared a report for the governing board or any actions taken by the

governing board. Simply put, Appellants provided no evidence of any activity

by the patient safety committee or the governing board on any matters

pursuant to section 310(b) from which the patient safety reports arose.

       In sum, based on our interpretation of section 311(a) and the record in

this appeal, we hold that a party claiming a document is protected under

section 311(a) need not demonstrate a patient safety committee or governing

board actually reviewed the contested document. At a minimum, however,

section 311(a) requires proof that the document, materials or information or

reporting requirement arose out of “matters reviewed” by a patient safety

committee      or   a   governing     board    pursuant   to   their   section   311(b)

responsibilities.18 Here, in the absence of any evidence that the patient safety

____________________________________________

17 We note Appellants also argue that the patient safety officer or office
functioned as the patient safety committee. This argument is frivolous and
ignores MCARE requirements, and their own patient safety plan and policy,
delineating the functions of a patient safety officer and a patient safety
committee or council.

18 Unlike an “actual review” standard, LVH could have proved their section
311(a) claim without the need for testimony from witnesses as to matters
learned while discharging their responsibilities as a member of a patient safety
committee or a governing board or by their participation in such meetings.
See 40 P.S. § 1303.311(b). For example, an “audit trail” of relevant
documents could have demonstrated that the patient safety committee or
governing board received or accessed the patient safety reports, a related
patient safety file, a related patient safety officer’s report, or a patient safety
committees’ report. See N.T., 3/31/22, at 26-30, 33.

                                          - 21 -
J-A17019-23

committee or governing board incorporated the three patient safety reports

when discharging their statutory responsibilities under section 310(b), we

conclude Appellants failed to meet their threshold burden of establishing the

evidentiary protection in section 311(a) applied. Accordingly, Appellants’ first

issue fails.19

       Before addressing Appellants’ remaining two issues concerning MCARE

section 311(d) and PRPA, we consider the trial court’s suggestion that

Appellants failed to preserve these issues for review.         The court asserts

Appellants only raised their claims for confidentiality under MCARE section

311(d) in a reconsideration motion. See Trial Court Opinion, 12/28/22, at 11

n.5.    The court also determined that Appellants waived their claim of

confidentiality under PRPA because they never objected to its initial June 2022

rulings that the PRPA privilege did not apply. See id. at 5 n.2.

       Our review of the unusual procedures giving rise to this appeal constrain

us to agree with the trial court that Appellants failed to preserve their appellate

claims based on MCARE section 311(d) and PRPA. In their initial objections

to Lahr’s request for discovery of the patient safety reports, Appellants cited

MCARE and PRPA generally. See Amended Privilege Log of LVH, 3/29/22, at

1-2; Supplemental Response of LVH and Group to Lahr’s Motion to Compel,

2/18/22, at 2-9 (discussing MCARE section 311(a) and PRPA). At the hearing

____________________________________________

19 It is well settled that this Court is not bound by the rationale of the trial
court and may affirm on any basis. See Southwestern Energy Production
Co. v. Forest Resources, LLC, 83 A.3d 177, 184 (Pa. Super. 2013).

                                          - 22 -
J-A17019-23

on Lahr’s motion to compel, Appellants argued that LVH and its healthcare

workers complied with the necessary MCARE procedures for reporting

incidents and serious events. Further, Appellants noted that LVH made two

incident reports to the PPSA and referred the three patient safety reports to

the peer review process.     However, Appellants did not cite MCARE section

311(d) or argue section 311(d) as an independent basis to protect the reports

sent to PPSA.    We acknowledge Drs. Young and Peters briefly mentioned

sections 313 and 311(d) in a supplemental brief filed after the hearing, see

Supplemental Memorandum of Drs. Young and Peters, 5/13/22, at 5. The

court, however, entered its June 2022 order rejecting Appellants’ MCARE and

PRPA claims and compelling production of the patient safety reports without

discussing section 311(d).

      Appellants thereafter filed their first reconsideration motion, which

focused on the trial court’s application of MCARE section 311(a), reliance on

Venosh, and conclusion that the information in the patient safety report was

otherwise available from an original source. The first reconsideration motion

did not cite or allege error under MCARE section 311(d) or PRPA.         At the

hearing on the first reconsideration motion, the trial court asked, “[W]e’re not

concerned with [PRPA] anymore?” to which Appellants’ counsel responded

“Correct, Your Honor.” See N.T., 9/19/22, at 7.       Again, while Appellants’

counsel mentioned that LVH submitted the two incident reports to the PPSA,

counsel did not cite or argue section 311(d). The trial court thereafter entered

the October 3, 2022 order vacating the June 2022 order and rejecting

                                     - 23 -
J-A17019-23

Appellants’ section 311(a) claim. It was only in the second reconsideration

motion, filed from the October 3, 2022 order, that Appellants re-raised a claim

that section 311(d) protected at least two of the patient safety reports. The

second reconsideration motion did not reassert Appellants’ PRPA claim.

      We acknowledge there is persuasive authority that the failure to include

a claim in optional reconsideration motions will not result in waiver of an

issue on appeal. Compare Jackson v. Hendrick, 764 A.2d 1139, 1142 n.5

(Pa. Cmwlth. 2000); 20 West's Pa. Prac., Appellate Practice § 302:59; with

Pa.R.Civ.P. 227.1(b)(2) (stating that the failure to state a ground for relief in

a mandatory post-trial motion will result in waiver).           Here, however,

Appellants bore the burden of establishing that an MCARE or PRPA protection

applied to the three patient safety reports. See Carlino, 260 A.3d at 197.

Appellants had ample opportunity to claim error based on the trial court’s

failure to consider MCARE section 311(d) and the court’s analysis of PRPA.

Their present attempts to revive dormant legal claims without preserving them

in the subsequent proceedings on their first reconsideration motion constitutes

impermissible piecemeal litigation.    See Meyer-Chatfield Corp. v. Bank

Financial Services Group., 143 A.3d 930, 938 n.4 (Pa. Super. 2016) (noting

that “[r]aising an issue for the first time in a motion for reconsideration . . .

does not rescue that issue from waiver”). We cannot condone such conduct

and conclude these issues are waived for the purpose of this appeal.         Cf.

Commonwealth v. Smith, --- A.3d ---, 2023 WL 6799100 at *4 (Pa. Super.

filed Oct. 16, 2023) (refusing to endorse a procedure that would force a party

                                      - 24 -
J-A17019-23

to relitigate a suppression motion indefinitely based on serial motions for

reconsideration by the opposing party).

      Order affirmed.   Lahr’s counsel to file a certification within five days

consistent with this decision.

Date: 12/15/2023

                                    - 25 -